Medtronic, St. Jude Ask CMS To Ease Restrictions On MRI-Cardio Trials
This article was originally published in The Gray Sheet
Executive Summary
Cardiac device makers Medtronic and St. Jude Medical want CMS to reconsider a proposal that would limit Medicare coverage of magnetic resonance imaging scans in patients with implanted heart devices to "ideal" clinical trials.
You may also be interested in...
Medtronic Revo MRI Pacer Approved, But Still Faces Reimbursement Hurdle
Medtronic is hoping that the immediate U.S. launch of its newly approved Revo MRI SureScan MRI-compatible pacemaker will help boost market share in the device category, but magnetic resonance imaging scans of implant recipients still face a key reimbursement hurdle.
Medtronic Revo MRI Pacer Approved, But Still Faces Reimbursement Hurdle
Medtronic is hoping that the immediate U.S. launch of its newly approved Revo MRI SureScan MRI-compatible pacemaker will help boost market share in the device category, but magnetic resonance imaging scans of implant recipients still face a key reimbursement hurdle.
CMS In Brief
Proposed rulemaking limits MRI coverage for pacemaker/defibrillator patients